STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancer, and infectious diseases, has announced its plans to release second quarter 2024 financial results on August 8, 2024, after the market close. The company will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the financial results and provide a general business update. The event will include a live Q&A session with analysts. Investors and interested parties can access the webcast through INOVIO's investor relations website. The webcast will be archived and available for replay for 90 days following the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that second quarter 2024 financial results will be released after the market close on August 8, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-2024-financial-results-on-august-8-2024-302206052.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (INO) release its Q2 2024 financial results?

INOVIO (INO) will release its second quarter 2024 financial results on August 8, 2024, after the market close.

What time is INOVIO's (INO) Q2 2024 earnings call scheduled for?

INOVIO's (INO) Q2 2024 earnings call is scheduled for 4:30 p.m. ET on August 8, 2024.

Where can I access INOVIO's (INO) Q2 2024 earnings webcast?

INOVIO's (INO) Q2 2024 earnings webcast can be accessed through the company's investor relations website at http://ir.inovio.com/events-and-presentations/default.aspx.

How long will INOVIO's (INO) Q2 2024 earnings webcast be available for replay?

INOVIO's (INO) Q2 2024 earnings webcast will be archived and available for replay for 90 days following the event.
Inovio Pharmaceu

NASDAQ:INO

INO Rankings

INO Latest News

INO Latest SEC Filings

INO Stock Data

141.53M
68.42M
0.51%
19.04%
12.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
PLYMOUTH MEETING